Document Actions

CV Prof. Dr. Michael Kracht



Professional career

since 2007 W3 Professorship for Pharmacology and Toxicology and Managing Director of the
Rudolf Buchheim Institute of Pharmacology of the Justus Liebig University Giessen
2007 Specialist for Pharmacology and Toxicology
2005 Professorship W2 for Molecular mechanisms of cytokine-mediated gene regulation at the Hannover Medical School (MHH)
2002 Extraordinary Professorship at the Hannover Medical School (MHH)
1999 Venia Legendi for the subject Molecularpharmacology at the MHH, title of the work: Molekulare Mechanismen der Entzündung: MAP Kinase Kinase 7 (MKK7) und stressaktivierte/Jun-NH2-terminale Proteinkinasen (SAPK/JNK) bilden ein zentrales Effektormodul bei der Signaltransduktion des pro-inflammatorischen Zytokins Interleukin-1
1995-2005 Academic Assistent and group leader at the Institute of Pharmacology, MHH
1992-1995 Post-doc as part of a Wellcome European Travelling Fellowship in the laboratory of
Dr. J. Saklatvala, Strangeways Research Laboratory, Cambridge and
AFRC Babraham Institute, Babraham, Great Britain, subject: Charakterisierung
und Identifizierung durch Interleukin-1 induzierte Zytosolische Serin/Threonin Proteinkinasen
1990-1992 Post-Doc as a part of a DFG Post-doc scholarship in the working group of
Prof. Dr. med. Marta Szamel at the Institute of Molecular Pharmacology, MHH,
leader: Prof. Dr. med. Klaus Resch, subject: Untersuchungen zur Aktivierung von Proteinkinase C durch Interleukin-1 in T-Lymphozyten
1988-1990 Doctor in internship and later assistance doctor at the hospital for Unfall-, Gefäß- und Abdominalchirurgie, leader: Prof. Dr. med. K. Reichel, Städtisches Krankenhaus Siloah, Hannover
1989 Graduation Dr. med. at the Hannover Medical School (MHH)
1986-1987 Experimental graduation at the Institute for Molecular Pharmacology of MHH, title of the work: Molekulare Mechanismen der Signalübertragung in T-Lymphozyten.
Die Rolle des Calciums und der Diglyceride bei der IL 2 Rezeptorexpression, der IL 2 Produktion und der Proliferation
1981-1988 Study of human medicine at the Hannover Medical School (MHH)


Memberships and Functions

2020- Project leader in the Research Training Group GRK 2573/1 The inflammatory tumor secretome – from understanding to novel therapies, Marburg
2019- Faculty member of the excellence cluster Cardio-Pulmonary Institute (CPI), Giessen
2018-2020 Board member of the Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie e.V. (DGPT)
2018- Member of the International Max Planck Research School
for Heart and Lung Research (IMPRS-HLR Faculty), Bad Nauheim
2016- Project leader in the DFG Clinical Research Group KFO 309
Virus-induced Lung
Injury: Pathobiology and Novel Therapeutic Strategies, Giessen
2016- Project leader in the DFG Collaborative Research Center SFB 1213
Pulmonary Hypertension and Cor Pulmonale
, Giessen
2013- Project leader in the DFG Collaborative Research Center SFB 1021
RNA viruses: RNA metabolism, host response and pathogenesis
, Marburg
2011- Member of Deutsches Zentrum für Lungenforschung (DZL)
2010- Project leader in the DFG Collaborative Research Center TRR 81
Chromatin Changes in Differentiation and Malignancies
, Giessen
2010- Faculty member of UGMLC Universities of Giessen and Marburg Lung Center
2009- Faculty member of ECCPS Excellence Cluster Cardio-Pulmonary System, Giessen
1998- Member of Signal Transduction Society (STS)
1998- Member of Deutsche Gesellschaft für Immunologie (DGFI)
1996- Member of Deutsche Gesellschaft für experimentelle und klinische Pharmakologie und Toxikologie e.V. (DGPT)

 

Reviewer for Immunity, Cell Reports., Nat Commun., Sci Rep., Sci Signal., Proc Natl Acad Sci U S A., Trends Biochem Sci., EMBO J., J Biol Chem., J Cell Biol., Trends Immunol., Oncogene., Nucleic Acids Res., Br J Pharmacol., PLoS One.,
J Leukocyte Biol., Exp Cell Research., Mol Med., Mol Cell Biochem., FEBS Letters, FEBS J., Biol Chem.,
Int J Cancer., Front Immunol., Blood, Cells.

Associate Editor for Naunyn Schmiedebergs Arch Pharmacol.

Associate Editor for Front Immunol.

Reviewer for Deutsche Forschungsgemeinschaft (DFG), Medical Research Council (MRC, UK), Helmholtz-Gemeinschaft Deutscher Forschungszentren e.V., Deutsche Krebsstiftung, Cancer Research UK, Arthritis Research UK, Science Foundation Ireland (SFI), APART (Austrian Programme for Advanced Research and Technology), Deutsches Krebsforschungszentrum (DKFZ), Reumafonds (NL), Alexander von Humboldt-Stiftung, Stichting tegen Kanker (Belgium)

 

Honours and Awards

2008 Genomic Pioneer Award, awarded on 30.09.2008 by Ocimum Biosolutions
at HUGO's International Genome Meeting held at Hyderabad, India

2008 Dolph Adams award of the Journal of Leukocyte Biology for the most highly
cited review article of years 2002-2007

The Dolph Adams Award and the state of the Journal of Leukocyte Biology

1998 Young Investigator Award 1998, 1. price, International Cytokine Society on the occasion of the "Second Joint Meeting of the International Cytokine Society (ICS) and the International Society for Interferon and Cytokine Research (ISICR)", Jerusalem, Israel